Health Prevention: An Overview of Hazardous Ingredients in Some Cosmetic Products Sold in Lomé (Togo)
DOI:
https://doi.org/10.14738/aivp.102.12094Keywords:
Hazardous ingredients; cosmetic products; pharmacy; market.Abstract
Introduction: Several substances used in cosmetic products can be dangerous for human health. These substances can induce a public health problem, especially in developing countries such as Togo; where there is no strict control regarding cosmetic products. The objectives of this study were to verify the presence of hazardous ingredients on the labels of cosmetics products.
Method: This study was a cross-sectional descriptive study, which focused on body and hygiene cosmetics, intended for children and adults, sold in pharmacies and in a market in Lomé.
Results: In total, 800 cosmetics products were studied, including 400 in pharmacies and 400 in the market. At the pharmacy as in the market, 244 no-rinse cosmetics products (milks, creams, serums, oils and lotions) and 156 rinse-off cosmetics products (bar and gel soaps) were evaluated. Hazardous ingredients were present both on the labels of cosmetic products collected at the pharmacy as well as at the market. But some hazardous ingredients were more frequent on the labels of the market cosmetic than on those of the pharmacy. Substances banned by the European Union such as hydroquinone and clobestasol propionate; allergenic and prohibited perfumes such as hydroxyisohexyl-3-cyclohexene carboxaldehyde; regulated preservatives as methylparaben and banned ingredients such as methylisothiazolinone and isobutylparaben; and unclassified dangerous depigmenting substances such as kojic acid and glutathione were the main families of hazardous ingredients identified on the labels of cosmetic products.
Conclusion: This study confirms the absence of a control and regulatory system concerning cosmetic products marketed in Lome (Togo).
References
EC (European Commission). Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 relating to cosmetic products. JO2009; 342: 59-209.
Ly F, Dangou JM, Ndiaye B, Maché A. Licken-like and pseudolupic dermatoses secondary to cosmetic use of products containing hydroquinone. Nouv Dermatol 2008; 27: 227-30.
Morand JJ ‚Ly F‚ Lightburn ‚Mahé A. Complication of cosmetic depigmentation in Africa. Med Trop 2007; 67 (6): 627-34.
ANSM (National Agency for the Safety of Medicines and Health Products). Assessment of the reprotoxic and / or endocrine disrupting risk associated with the use of cyclotetrasiloxane (D4) in cosmetic products. ANSM 2013.
ANSM. Ingredients in cosmetic products incriminated by the Committee for Sustainable Development in Health (C2DS). ANSM 2010.
Bennike NH, Oturai NB, Müller S, Kirkeby CS, Jørgensen C, Christensen AB, et al. Fragrance contact allergens in 5588 cosmetic products identified through a novel smartphone application. J Eur Acad Dermatol Venereol 2018; 32 (1): 79-85. doi: 10.1111/jdv.14513.
Uter W, Gonçalo M, Yazar K, Kratz EM, Mildau G, Lidén C. Coupled exposure to ingredients of cosmetic products: I. Fragrances, Contact Derm 2013; 69 (6): 335-41. doi: 10.1111/cod.12125
Burnett CL, Bergfeld WF, Belsito DV, et al. Final report of the safety assessment of kojic acid as used in cosmetics. Int J toxicol 2010; 29 (6_suppl): 244S-73S. doi: 10.1177/1091581810385956.
DGCCRF (Directorate General for Competition, Consumption and Fraud Control). Presence of preservatives prohibited in cosmetic products. DGCCRF 2017.
Glèlè-Ahanhanzo, Kpozehouen A, Maronko B, Azandjèmè C, Mongbo V, Sossa-J C. Voluntary depigmentation in women in a region of southwestern Benin. Pan Afr Med J 2019; 33: 2-10.
Traore A, Kadeba JC, Niamba P, Barro F, Ouedraogo L. Use of cutaneous depigmenting products by women in two towns in Burkina Faso: epidemiologic data, motivations, products and side effects. Int J Dermatol 2005; 44: 30-2. doi: 10.1111/j.1365-4632.2005.02807.x.
Mahé A, Ly F, Aymard G, Dangou JM. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal. Br J Dermatol 2003; 148 (3): 493-500.
UEMOA (West African Economic Monetary Union). Annex to decision No. 07/2010 / CM / UEMOA adopting guidelines for the approval of cosmetic products in UEMOA member states. doi: 10.1046/j.1365-2133.2003.05161x.
UEMOA. Decision No. 07/2010 / CM / UEMOA adopting guidelines for the approval of cosmetic products in the member states of UEMOA.
Ivory Coast. Decree No. 2015-288 of April 29, 2015 on the regulation of cosmetic products and personal hygiene products.
Nigeria. NAFDAC (National Agency for Food and Drug Administration and Control), Cosmetic products (prohibition of bleaching agents) regulations NAFDAC 2018.
C2DS (Committee for sustainable development in health). The baby cosmetics industry ensures the surety of maternity hospitals. ANSM 2008.
Pitché P, Afanou A, Amanga Y, Tchangaï-Walla K. The depigmenting cosmetic practices of women in Lomé (TOGO). Med Afr Noire 1998; 45 (12): 709-13.
Migan N. Study of depigmenting agents and their misuse in voluntary depigmentation. Sci pharm 2013; 201.
US FDA. Supporting information for toxicological evaluation by the national toxicology program. Proposed Rule: Reclassifies hydroquinone as non monograph; withdraws final attempt monograph. HHS 2006 ; 71 (167): 34273-93.
Sylla R, Diouf A, Niane B, N'diaye B, Guisse MB, Diop A, et al. Practice of artificial depigmentation of the skin in women in Dakar and analytical study of cosmetic products used. Dakar Med 1994; 39 (2): 223-6.
Gbetoh MH, Amyot M. Mercury, hydroquinone and clobetasol propionate in skin lightening products in West Africa and Canada. Approximately Res 2016; 150: 403-10. doi: 10.1016/j.envres.2016.06.030
Ake M, OGA S, Bony N, et al. Research and determination of clobetasol 17 - propionate and betamethasone 17-, 21 - dipropionate in creams and gels sold on public markets in Abidjan (Côte d'Ivoire). J Sci Pharm Biol 2007; 8: 25-33.
ANSM / DGCCRF. Warning on the risks associated with the practice of voluntary depigmentation of the skin. ANSM 2011.
Thierno Mt, Diop Ng, Niang So, et al. Bacterial dermohypodermitis and artificial depigmentation: About 60 cases observed in Senegal. Nouv dermatol 2001; 20 (10): 630-2.
Ly F, Diousse P, Ndiaye C, Démé A, et al. Squamous cell carcinomas associated with voluntary cosmetic depigmentation: 8 cases reported in Senegal. Ann Dermatol Venereol 2018; 145 (2): 83-8. doi.org/10.1159/000504596
Akapko AS, Mouhari-Toure A, Saka B, Téclessou J, Kombaté K, Tchangaï-Walla K, Pitché P. Systemic complications during voluntary depigmentation in women in Togo: case-control study. Ann Dermatol Venereol 2016; 143 (4): 197-201.
Buckley DA. Fragrance ingredient labeling in products on sale in the UK Br J Dermatol 2007; 157 (2): 295-300. doi: 10.1111/j.1365-2133.2007.08018.x.
ANSM. Directive 2003/15 / EC which obliges the 26 aromatic substances to be labeled on cosmetic products. ANSM 2004; bulletin n ° 23.
Van Oosten EJ, Schuttelaar MLA, Coenraads PJ. Clinical relevance of positive patch test reactions to the 26 EU-labeled fragrances. Contact Derm 2009; 61 (4): 217-23. doi.org/10.1016/j.annder.2015.06.023
EU (European Union). Commission Regulation (EU) 2017/1410 of 2 August 2017 amending Annexes II and III of Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products. OG 2017.
Pastor-Nieto MA, Alcántara-Nicolás F, Melgar-Molero V, et al. Preservatives in personal hygiene and cosmetic products, topical medications, and household cleaners in Spain. Actas Dermosifiliogr 2017; 108 (8): 758-70. doi: 10.1016/j.ad.2017.04.003.
Steinberg DC. Frequency of preservative use update through 2014. C & T 2016; 131: 56-60
ANSM. Risk assessment related to the use of parabens in cosmetic products. ANSM 2005; vigilance bulletin n ° 30.
EC. Opinion on phenoxyethanol. SCCS / 1575/16 Final version of 6 October 2016.
EC. Summary report from the public consultation on methylisothiazolinone in the framework of regulation EC N °. 1223/2009 of the european parliament and of the council on cosmetic products. EC 2015; 5497540.
Latorre N, Silvestre JF, Monteagudo AF. Allergic contact dermatitis caused by formaldehyde and formaldehyde releasers. Actas Dermosifiliogr 2011; 102 (2): 86-97. doi: 10.1016/j.ad.2010.09.004.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Diallo Aboudoulatif
This work is licensed under a Creative Commons Attribution 4.0 International License.
